Protein Modeling to Assess the Pathogenicity of Rare Variants of SERPINA1 in Patients Suspected of Having Alpha 1 Antitrypsin Deficiency

BMC Medical Genetics - United Kingdom
doi 10.1186/s12881-019-0852-5
Full Text
Abstract

Available in full text

Categories
Genetics
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Safety and Efficacy of Alpha-1-Antitrypsin Augmentation Therapy in the Treatment of Patients With Alpha-1-Antitrypsin Deficiency

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2009English

Alpha-1-Antitrypsin Deficiency

2020English

Alpha-1 Antitrypsin Deficiency

Journal of insurance medicine (New York, N.Y.)
Medicine
2015English

Alpha‐1‐Antitrypsin Deficiency

English

Alpha-1 Antitrypsin Deficiency in Patients With Chronic Hepatitis

Turkish Journal of Gastroenterology
Gastroenterology
2012English

Orphan Designation: Alpha-1 Antitrypsin (Inhalation Use), Treatment of Emphysema Secondary to Congenital Alpha-1-Antitrypsin Deficiency

Case Medical Research
2019English

The Prevalence of Alpha-1 Antitrypsin Deficiency in Ireland.

2009English

333. Simultaneous Disruption of Five SerpinA1 Genes in Mice Using CRISPR/Cas9 to Generate the First Animal Model of Alpha-1 Antitrypsin Deficiency

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

Deficient and Null Variants of SERPINA1 Are Proteotoxic in a Caenorhabditis Elegans Model of Α1-Antitrypsin Deficiency

PLoS ONE
Multidisciplinary
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy